📰 Epithelial Cells News
Page 2 - Epithelial Cells News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Epithelial Cells. Real-time updates on events, politics, business and more.
August 31, 2022
Regulatory approval for proof of pharmacology study for the first non-antibiotic macrolideREYKJAVIK, Iceland, August 31, 2022 / B3C newswire / -- EpiEndo Pharmaceuticals (‘EpiEndo’), the clinical-stage biopharmaceutical company developing disease-modifying therapeutics for chronic respiratory disorders, has received...
May 18, 2022
First non-antibiotic macrolide to go into clinical development – targeting COPDSafety, tolerability and pharmacokinetic endpoints metPhase II planning underwayREYKJAVIK, Iceland, May 18, 2022 / B3C newswire / -- EpiEndo Pharmaceuticals (‘EpiEndo’), the clinical-stage biopharmaceutical company developing disease-modi...
March 24, 2022
REYKJAVIK, Iceland, March 24, 2022 / B3C newswire / -- EpiEndo Pharmaceuticals is pleased to announce the appointment of Stefan Petursson as Chief Financial Officer (CFO), starting 1 April 2022. EpiEndo Pharmaceuticals is a privately held biopharmaceutical company developing a therapeutic pipeline for the treatment...
March 1, 2022
Corantin Maurin and colleagues investigate the capacity of human cornea to be infected by SARS-CoV-2 virus and evidence for viral detection in corneas from donors with a positive test for SARS-CoV-2 infection.
February 8, 2022
In a recent study published in the journal ACS Applied Bio Materials, researchers demonstrated the inhibitory potential of curcumin-encapsulated polysaccharide nanoparticles (CUR−PS-NPs) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (CoV2-SP)-stimulated cytokine storm in lung and liver epithelial cells.
August 25, 2021
Certain steroid-like compounds from Taiwan's endemic medicinal mushrooms (known as antcins) may inhibit a host cell receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and, thus, prevent viral infection and subsequent development of the coronavirus disease (COVID-19), reports a new study published in the MDPI's journal Plants.
August 19, 2021
Forscher haben herausgefunden, dass die Abwehr in den oberen Atemwegen bei Kindern wesentlich aktiver ist als bei Erwachsenen.
August 12, 2021
Darmerkrankungen: Neuer Therapieansatz? Blutiger Durchfall, krampfartige Bauchschmerzen, Appetitlosigkeit und Übelkeit: die Symptome chronisch-entzündlicher Darmerkrankungen sind für die Betroffenen äußerst schmerzhaft
May 4, 2021
The first comprehensive single-cell atlas of the human tooth reveals how different dental tissues control the activity of stem cells.
February 4, 2021
Lactoferrin can enhance antiviral immune response to COVID-19 infection, according to a newly published study in cells. Lactoferrin (LF) is a protein found naturally in milk from humans and cows as well as other bodily fluids, which has shown potential in fighting viral and bacterial infections and to exert anti-inflammatory and immune-modulating activity (1,2). The LF antiviral effect occurs by preventing the entry of viral particles into the host cells, ...